Radiopharm Theranostics Accelerates Phase 1 Clinical Trial of 177Lu-RAD204 Following Positive DSMC Review 13·05·2025
Neutralizing Viruses at the Source: Engineered Antibodies in Mosquitoes Offer New Hope Against Arbovirus Threats 08·05·2025
Precision Engineering of Nanobodies via Site-Specific Lysine Modification and KAT Ligation 24·04·2025